Vera Therapeutics

Our Science


Effect of Atacicept on Renal Function in SLE Patients

Isenberg et al. (2022) ERA-EDTA Congress

Atacicept Reduces Serum Gd-IgA1 by Quartiles in IgAN Patients

Barratt et al. (2021) American Society of Nephrology

Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy

Thompson, A. et al. (2019) Clinical Journal of the American Society of Nephrology

New strategies and perspectives on managing IgA nephropathy

Selvaskandan, H. et al. (2019) Clinical and Experimental Nephrology

Profile of atacicept and its potential in the treatment of systemic lupus erythematosus

Cogollo, E. et al. (2015) Drug Design, Development and Therapy

IgA Nephropathy

Wyatt, R. and Julian, B. (2013) New England Journal of Medicine

An update on the pathogenesis and treatment of IgA nephropathy

Boyd, J. et al. (2012) Kidney International

Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels

Moldoveanu, Z. et al. (2007) International Society of Nephrology 

A First-in-Human Study of MAU868, a Novel Neutralizing Antibody Against BK Virus

Kovacs et al. (2020) ASH Annual Meeting and Exposition